4195 Kimi Innovation - Full Board of Directors Re-elected at 115th Annual Shareholders Meeting
AI Summary (NQ-processed)
Kimi Innovation announced the full re-election of its board of directors, including independent directors, at its 115th annual shareholders meeting. All previous directors were re-elected, with Wu Chun-Yi appointed as the new legal representative of the corporate director.
AI Analysis
Frequently Asked Questions
Q: What was the outcome of Kimi Innovation's board election?
A: All directors were re-elected, with Wu Chun-Yi appointed as the new corporate representative. This was a routine election due to term expiration.
Q: What are the shareholdings of the newly elected directors?
A: Chou Meng-Hsien holds over 2.5 million shares, Wu Chun-Yi over 4.94 million. Independent directors hold zero shares.
Q: What does Kimi Innovation do?
A: It focuses on healthcare collaboration, policy advocacy, and patient support services in Taiwan.
Q: What is the board turnover rate?
A: Though all were re-elected, the change in corporate representative counts as over one-third turnover.
Q: Who are the major shareholders of Kimi Innovation?
A: Junmao International Co., Ltd. is the major shareholder, holding over 4.94 million shares.